Another Ranitidine Recall Announced by the FDA
WASHINGTON, D.C. — American Health Packaging announced a voluntary recall of ranitidine tablets, USP150 mg, in 100-count blister packs after finding a potential human carcinogen in the medication. According to an announcement published by the U.S. Food and Drug Administration (FDA), American Health Packaging said that the recall is … [Read more...] about Another Ranitidine Recall Announced by the FDA
Another Ranitidine Recall Announced by the FDA
WASHINGTON, D.C. — American Health Packaging announced a voluntary recall of ranitidine tablets, USP150 mg, in 100-count blister packs after finding a potential human carcinogen in the medication. According to an announcement published by the U.S. Food and Drug Administration (FDA), American Health Packaging said that the recall is … [Read more...] about Another Ranitidine Recall Announced by the FDA
Another Ranitidine Recall Announced by the FDA
WASHINGTON, D.C. — American Health Packaging announced a voluntary recall of ranitidine tablets, USP150 mg, in 100-count blister packs after finding a potential human carcinogen in the medication. According to an announcement published by the U.S. Food and Drug Administration (FDA), American Health Packaging said that the recall is … [Read more...] about Another Ranitidine Recall Announced by the FDA
Another Ranitidine Product Recalled
BRIDGEWATER, New Jersey — Amneal Pharmaceuticals, LLC, from Bridgewater, New Jersey announced that the company would recall several lots of its Ranitidine products because of N-Nitrosodimethylamine (NDMA) impurities found in its products. Scientists have identified NDMA as a potential carcinogen. NDMA exists in much of the food … [Read more...] about Another Ranitidine Product Recalled
